Amanote Research
Register
Sign In
Survival Analysis in Patients With Low-Grade Glioma Using Data From the National Cancer Database 2013 Participant User File
International Journal of Radiation Oncology Biology Physics
- Netherlands
doi 10.1016/j.ijrobp.2017.06.776
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Date
October 1, 2017
Authors
T. Gunter
S. Chen
O. Algan
Publisher
Elsevier BV
Related search
Defining an Intermediate-Risk Group for Low-Grade Glioma: A National Cancer Database Analysis
Anticancer Research
Medicine
Cancer Research
Oncology
Low Grade B-Cell Non-Hodgkin Lymphomas Involving the Central Nervous System: An Analysis From the National Cancer Database
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Clinical Management of Seizures in Patients With Low-Grade Glioma
Seminars in Radiation Oncology
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Conditional Survival of Patients With Hepatocellular Carcinoma Undergoing Curative Intent Resection: Analysis of the National Cancer Database
HPB
Hepatology
Gastroenterology
Use of Metformin and Survival of Patients With High-Grade Glioma
International Journal of Cancer
Cancer Research
Oncology
Pcn65 - Long- Term Survival Among Patients With High-Grade Glioma Treated With Nimotuzumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Determinants of Survival in Oral Cavity Cancer Patients: An Analysis of the National Cancer Data Base (NCDB)
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Disparities in Survival Among Patients With Pancreatic Neuroendocrine Tumor Using the National Cancer Database: Effects of Insurance Status and Treatment Facility
HPB
Hepatology
Gastroenterology
Is Less More? Comparing Chemotherapy Alone With Chemotherapy and Radiation for High-Risk Grade 2 Glioma: An Analysis of the National Cancer Data Base
Cancer
Cancer Research
Oncology
